Back to Hood River Capital Management LLC Hood River Capital Management LLC

CYTKCYTK
Showing 7 of 19 quarters

Position history for Hood River Capital Management LLCHood River Capital Management LLC's holdings in CYTOKINETICS INC

Yes. Hood River Capital Management holds 469,273 shares of CYTK (Cytokinetics), worth $40M, as of its Q2 2026 13F filing. It opened the position in Q2 2026. CYTK is 0.3% of Hood River Capital Management's reported 13F portfolio.

Current Value

$40M

Current Shares

469,273

Total Value Change

-$12.3M

Total Shares Change

-521,523

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
469,273
-
$40M0.3%$85.19
48
2026-Q1
Exited
0
-100.0%
$00.0%$65.91
0
2025-Q4
New
137,597
-
$8.7M0.1%$63.54
38
2025-Q2
Exited
0
-100.0%
$00.0%$33.04
0
2025-Q1
Increased
1.3M
+27.0%
$50.5M0.9%$40.19
51
2024-Q4
Decreased
989,248
-0.2%
$46.5M0.7%$47.04
0
2024-Q3
Increased
990,796
+34.3%
$52.3M0.8%$52.80
53

Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used